- Source : Press Release
- Date : 2021-04-22
- Event type : Research
- Companies : Roche
In 2017, Idorsia entered into a research collaboration with Roche in the field of cancer
immunotherapy. In the first quarter of 2021, the agreement was terminated. Idorsia continues drug
discovery efforts on this promising molecular target.